A stock that had once flown under the radar has quietly surged more than 300% since April 2025, climbing from a low of $6.27 per share to $26.43 by the end of August. Although the company had reached a high of $50 in 2024, it successfully transformed into a closely watched artificial intelligence concept stock after the electric vehicle market cooled. Neither investors nor the company itself may have fully anticipated the AI opportunities lying behind this shift.
The company is called Aehr Test Systems (AEHR), and its core business lies in providing critical semiconductor reliability testing systems for the AI and data center industries. When hyperscale companies build massive data centers housing tens of millions or even hundreds of millions of chips, chip reliability directly impacts operational costs and system stability. High failure rates can lead to significant repair expenses, manpower investments, and downtime losses—even creating opportunities for competitors to gain ground. Aehr’s testing systems exist to solve this very problem. As the importance of reliability testing grows exponentially, Aehr has regained market favor.
Currently, the construction of hyperscale data centers is advancing rapidly worldwide. Tech giants such as Meta, Amazon, and Musk’s xAI are investing heavily in building astonishingly large data center campuses. This demand is primarily driven by artificial intelligence, which is also a key reason why Aehr has been reclassified as an “AI stock” and continues to see its share price rise.
Despite promising prospects, Aehr still faces practical challenges. In fiscal year 2025, its revenue fell to $59 million from $66 million the previous year, and operating profit shifted from a gain of $10 million to a loss of $6 million, reflecting the transitional difficulties the company experienced during its strategic adjustment. However, positive signals have already emerged: the company’s order backlog jumped from $7 million to $15 million, and it has recently announced a series of orders from hyperscale data center operators.
Valuing Aehr at this stage presents certain challenges. The company is still in the early phases of its transformation, and the contribution of its AI business has not yet been fully realized. At its historical peak, the stock’s price-to-sales ratio reached 31 times; as recently as August 2023, it stood at 24 times, while currently it is only at 12 times. As the AI market continues to boom, Aehr is poised to benefit deeply from industry demand, and its stock may usher in new growth opportunities.
